[CAS NO. 2414674-71-6]  SUVN-911

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2414674-71-6]

Catalog
AS980210
Brand
Arctom Scientific
CAS
2414674-71-6

DESCRIPTION [2414674-71-6]

Overview

MDL-
Molecular Weight261.15
Molecular FormulaC11H14Cl2N2O
SMILESClC1=NC=C(OC[C@H]2N[C@@H]3C[C@@H]3C2)C=C1.[H]Cl

For research use only. We do not sell to patients.

Summary

SUVN-911 is a potent, selective, brain penetrated and orally bioavailable neuronal nicotinic acetylcholine α4β2 receptor antagonist, with a K i of 1.5 nM. SUVN-911 has antidepressant activity [1] .


IC50 & Target

Ki: 1.5 nM (α4β2 receptor) [1]


In Vitro

SUVN-911 displays high selectivity for α4β2 over α3β4 nAChR [1] .
SUVN-911 shows good selectivity against over 70 receptors which includes GPCRs, ion channels, enzymes, peptides, steroids, second messengers, growth factors and prostaglandins [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

SUVN-911 is devoid of cardiovascular and gastrointestinal side effects [1] .
SUVN-911 (1.0-10.0 mg/kg; p.o.; daily; for 3 days) shows significant antidepressant effects [1] .
SUVN-911 shows metabolic stability in rats [1] .
SUVN-911 (3 mg/kg; p.o.) has shown high oral exposures, longer half-lives and adequate brain penetration in Wistar rats [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Wistar rats (180-230 g) [1]
Dosage: 1 mg/kg, 3 mg/kg, 10.0 mg/kg
Administration: Oral administration, daily, for 3 days
Result: Showed antidepressant like activity with no signs of tachyphylaxis.
Animal Model: Male Wistar rats (225 ± 25 g) [1]
Dosage: 3 mg/kg (Pharmacokinetic Analysis)
Administration: Oral administration
Result: AUC=3507 ng*h/mL, T 1/2 =3.34 hours.

Clinical Trial

NCT Number Sponsor Condition Start Date Phase
NCT03551288 Suven Life Sciences Limited
Major Depressive Disorder
May 22, 2018 Phase 1
NCT03155503 Suven Life Sciences Limited
Depressive Disorder, Major
May 22, 2017 Phase 1

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 125 mg/mL ( 478.65 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.8292 mL 19.1461 mL 38.2922 mL
5 mM 0.7658 mL 3.8292 mL 7.6584 mL
10 mM 0.3829 mL 1.9146 mL 3.8292 mL
* Please refer to the solubility information to select the appropriate solvent.